Mr. Speaker, I do not agree.
Any cabinet minister who had even the slightest involvement with the blood products industry in the eighties would have been in conflict sitting at the cabinet table when they were discussing compensation packages for tainted blood victims.
The finance minister sat on the board of a company whose subsidiary was cited by the Krever commission for 10 counts of misconduct.
The minister must be concerned about what is in those minutes and why they are being sat on. Why else would he send a finance official to Calgary along with the ethics counsellor?